Stimcell Energetics (STME) Operating Income (QoQ) (2016 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Stimcell Energetics | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2024 | -102.44% |
| Feb 29, 2024 | -35.74% |
| Nov 30, 2023 | 16.63% |
| Aug 31, 2023 | 21.18% |
| May 31, 2023 | 38.80% |
| Feb 28, 2023 | 19.85% |
| Nov 30, 2022 | 8.93% |
| Aug 31, 2022 | 5.91% |
| May 31, 2022 | -36.81% |
| Feb 28, 2022 | 33.95% |
| Nov 30, 2021 | 27.25% |
| Aug 31, 2021 | -30.98% |
| May 31, 2021 | -5.29% |
| Feb 28, 2021 | 6.33% |
| Nov 30, 2020 | 6.83% |
| Aug 31, 2020 | 20.85% |
| May 31, 2020 | 3.21% |
| Feb 29, 2020 | 15.17% |
| Nov 30, 2019 | -25.75% |
| Aug 31, 2019 | 80.19% |
| May 31, 2019 | -820.14% |
| Feb 28, 2019 | 33.79% |
| Nov 30, 2018 | -48.17% |
| May 31, 2017 | -45.55% |
| Feb 28, 2017 | -21.58% |
| Nov 30, 2016 | 6.02% |
| Aug 31, 2016 | 18.66% |
| May 31, 2016 | -10.11% |